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ABSTRACT
Genetic screens in Saccharomyces cerevisiae have
identified the roles of ribosome components, tRNAs
and translation factors in translational fidelity. These
screens rely on the suppression of altered start
codons, nonsense codons or frameshift mutations
in genes involved in amino acid or nucleotide meta-
bolism. Many of these genes are regulated by the
General Amino Acid Control (GAAC) pathway. Upon
amino acid starvation, the kinase GCN2 induces the
GAAC cascade via increased translation of the tran-
scriptional activator GCN4 controlled by upstream
open reading frames (uORFs). Overexpression of
the GCN2 or GCN4 genes enhances the sensitivity
of translation fidelity assays that utilize genes
regulated by GCN4, such as the suppression of a
11 insertion by S.cerevisiae translation elongation
factor 1A (eEF1A) mutants. Paromomycin and the
prion [PSI1], which reduce translational fidelity,
do not increase GCN4 expression to induce the
suppression phenotype and in fact reduce derepres-
sion. eEF1A mutations that reduce translation,
however, reduce expression of GCN4 under non-
starvation conditions. These eEF1A mutants also
reduce HIS4 mRNA expression. Taken together, this
system improves in vivo strategies for the analysis
of translational fidelity and further provides new
information on the interplay among translation
fidelity, altered elongation and translational control
via uORFs.
INTRODUCTION
Protein synthesis plays a key role in the efﬁcient and accurate
gene expression program required in all cells. The ribosome
and soluble protein factors are essential for all steps of protein
synthesis. Using the yeast Saccharomyces cerevisiae, many
protein synthesis factors were ﬁrst identiﬁed as a consequence
of their effects on the accuracy of the translation process.
These include the translation initiation factor eIF2 subunits
identiﬁed in a screen for mutations that affect start site selec-
tion (1) as well as the termination factor eRF3, which is
responsible for the [PSI+] omnipotent nonsense suppression
phenotype (2).
Many screens for the identiﬁcation of factors that alter
translational ﬁdelity rely on the suppression of altered start
codons, nonsense codons or frameshift mutations in genes
involved in amino acid or nucleotide metabolism [reviewed
in (3)]. Several of the targets of the GCN4 transcription factor
have alleles utilized to assess effects in ﬁdelity, including
LYS2, TRP1, LEU2 and HIS4 (4). These mRNAs are typically
expressed at low levels, thus the identiﬁcation of mutations
that suppress these alleles can be difﬁcult. In the case of the
well-characterized [PSI+] prion of yeast, the ability to increase
the sensitivity for in vivo analysis of the presence of this
element, and the resulting nonsense suppression phenotype,
is facilitated by combining an allele of the ADE2 gene with
an UAA nonsense mutation (ade2.1) and a speciﬁc UAA
suppressor tRNA encoded by SUQ5 (5).
One possibility is to increase the sensitivity of a wider range
of screens for altered ﬁdelity by using the GCN2 and GCN4
genes. Both genes are components of the General Amino Acid
Control (GAAC) system that increases the expression,
indirectly and directly, of a large array of genes belonging
to metabolic pathways [reviewed in (6)]. The eukaryotic
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in all eukaryotes, and is stimulated by serum or amino acid
starvation. The ultimate signal for amino acid starvation is
uncharged tRNA that binds to the histidyl-tRNA synthetase
(HisRS)-like domain in GCN2 (7). Phosphorylation of the
a-subunit of eIF2 is a key mechanism for adjusting the rate-
of protein synthesis in response to starvation or stress.
Phosphorylation of eIF2a converts eIF2 to a competitive
inhibitor of the guanine nucleotide exchange factor eIF2B
leading to low levels of ternary complex (TC) [reviewed
in (6)].
Through phosphorylation of eIF2a, GCN2 plays a dual role
in down-regulating general translation and speciﬁcally up-
regulating translation of the transcriptional activator GCN4.
The latter is accomplished by four short upstream open read-
ing frames (uORFs) in the GCN4 mRNA (8). Under amino
acid-replete conditions, ribosomes translate uORF1, resume
scanning and reacquire a TC before reaching uORF2, uORF3
or uORF4. Following translation of these latter uORFs, the
majority of ribosomes disassociate from the mRNA so that
only a small fraction of ribosomes reach the GCN4 ORF,
resulting in low GCN4 translation. Phosphorylation of eIF2a
by GCN2 in amino acid starved cells lowers the level of TC.
Consequently, after the translation of uORF1, ribosomes
re-acquire the TC after they have scanned through uORF2,
uORF3 and uORF4 and instead reinitiate at the GCN4 ORF
leading to high GCN4 protein levels. Increased GCN4
protein levels subsequently stimulate transcription of GCN4
target genes, including those encoding numerous amino acid
biosynthetic enzymes from 12 different pathways [reviewed
in (4)].
In this paper we demonstrate the utility of overexpression
of GCN2 or GCN4 to enhance the sensitivity of assays for
altered translational ﬁdelity in the yeast S.cerevisiae. Over-
expression of either protein allows enhanced growth on
selective media and thus increased the assay sensitivity for
translation elongation factor 1A (eEF1A) mutants that specif-
ically suppress a +1 insertion. Since these mutations affect
translational ﬁdelity, and GCN4 expression is controlled at
the translational level by uORFs, we determined the effect
of reduced ﬁdelity on GCN4 expression. These results
demonstrate a novel approach to improve in vivo strategies
for the analysis of translational ﬁdelity as well as the
impact of altered ﬁdelity on translational control of GCN4
expression.
MATERIALS AND METHODS
Strains and media
Escherichia coli DH5a cells were used for plasmid prepara-
tion. S.cerevisiae strains used in these studies are listed in
Table 1. Standard yeast genetic methods were employed
(9,10). Yeast cells were grown in either YEPD (1% Bacto
yeast extract, 2% peptone and 2% dextrose) or deﬁned
synthetic complete media (C or C-) supplemented with 2%
dextrose as a carbon source. Yeast cells were transformed by
the lithium acetate method (11).
Growth assays
Streaks of yeast cells expressing empty vector (pRS316) or
plasmids expressing GCN2 (p722), GCN2
cconstitutive mutant
alleles E803V (p1253), M788V (p912) or M788V-E1591K
(p1055) (12), or GCN4 (p164), GCN4 with uORF1 (p235),
or GCN4 with no uORFs (p238) (13) were maintained on
C-Ura media and assayed for growth via increased expression
of the his4-713 gene product on C-Ura-His media following
7 days of growth at 30 C. Solid media testing of sensitivity to
paromomycin and cycloheximide in C-Ura media was per-
formed via a lawn assay as described previously (14). Growth
inhibition was monitored as the zone of inhibition of growth
from the ﬁlter disc (in mm) repeated at least in triplicate.
Liquid growth assays of wild-type strains in the presence of
paromomycin or cycloheximide and for [PSI+] strains were
performed using mid-log phase cells grown in YEPD or
complete media and were diluted to an A600 of 0.1 or 0.2
and were incubated with a range of concentrations of the
various compounds at 30 C in 96-well microtiter plates. All
experiments were performed in triplicate and were repeated at
least three times.
Assays of GCN4-lacZ reporter expression
Strains were transformed with the GCN4 lacZ reporterplasmid
[p180 (8)] and were maintained on C-Ura media. Cells were
grown in C-Ura-Val-Ile medium for 2 days to saturation and
were diluted to an A600 of 0.8. The sulfonylurea herbicide
sulfometuron methyl (SM), an inhibitor of leucine, isoleucine
and valine biosynthesis (15), was added to a ﬁnal concentra-
tion of 2 mg/ml and the cells were grown for 6 h to induce
starvation (16). To assess the effect of paromomycin or cyclo-
heximide on reporter expression, the indicated drug was added
to cells at the same time as the addition of SM. Extracts were
Table 1. S.cerevisiae strains
Strain Genotype Reference
MC214 MATa ura3-52 trp1-D101 lys2-20 leu2-3,112 met2-1 his4-713 tef1::LEU2 tef2-D pTEF2 TRP1 (20)
TKY225 MATa ura3-52 trp1-D101 lys2-20 leu2-3,112 met2-1 his4-713 tef1::LEU2 tef2-D ptef2-17 TRP1 D156N (19)
TKY226 MATa ura3-52 trp1-D101 lys2-20 leu2-3,112 met2-1 his4-713 tef1::LEU2 tef2-D ptef2-19 TRP1 N153T (19)
TKY229 MATa ura3-52 trp1-D101 lys2-20 leu2-3,112 met2-1 his4-713 tef1::LEU2 tef2-D ptef218 TRP1 D156E N153T (19)
TKY252 MATa ura3-52 trp1-D101 lys2-20 leu2-3,112 met2-1 his4-713 tef1::LEU2 tef2-D pTEF2-4 TRP1 E122K (24)
TKY235 MATa ura3-52 trp1-D101 lys2-801 leu2D1 met2-1 his4-713 tef5::TRP1 pTEF5 URA3 (14)
TKY243 MATa ura3-52 trp1-D101 lys2-801 leu2D1 met2-1 his4-713 tef5::TRP1 ptef5-7 LEU2 K120R S121D I122D (14)
TKY588 MATa ura3-52 trp1-D101 lys2-20 leu2-3,112 met2-1 his4-713 tef1::LEU2 tef2-D pTEF2-1 TRP1 E286K (22)
TKY597 MATa ura3-52 trp1-7 lys2 leu2-3,112 met2-1 his4-713 yef3::LEU2 pYEF3 TRP1 (24)
TKY599 MATa ura3-52 trp1-7 lys2 leu2-3,112 met2-1 his4-713 yef3::LEU2 pyef3 TRP1 F650S (24)
628-3Aay+ MATa ura3-52 kar1.1 ade2.1 SUQ5 trp1D63 leu2-D1[PSI+] (5)
628-3Aay  MATa ura3-52 kar1.1 ade2.1 SUQ5 trp1D63 leu2-D1[psi ] (5)
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viously (8). In all cases identical cultures were grown at the
same A600 and for the same time in the absence of SM to
determinenon-starvationlevelsofexpression.Allexperiments
were performed in a minimum of triplicate.
Northern blot analysis
MC214 or TKY252 expressing empty vector (pRS316), the
E803V GCN2
c constitutive mutant allele (p1253) or GCN4
with no uORFs (p238) (13) were grown in C-Ura media at an
A600 of 0.6–1.0, harvested by centrifugation and total RNA
was isolated as described previously (17). RNA (20 mg) was
separated on a 1.4% formaldehyde agarose gel, transferred
onto Hybond
+ membranes overnight by capillary action and
crosslinked to the membrane with a Spectrolinker XL-1000
(Spectronics). Hybridization and detection were performed as
per the ExpressHyb protocol (Clontech).
32P-labeled probes
for yeast HIS4 and ACT1 mRNAs were prepared using the
Rad Prime Labeling System kit (Invitrogen). Radioactive
signals were detected using a Phosphoimager Typhoon
9410 (Molecular Dynamics) and quantiﬁed with the Image-
Quant program (Molecular Dynamics).
RESULTS
Expression of an activated form of the eIF2a kinase
GCN2 increases the readout of a reporter allele of
reduced translational fidelity in eEF1A mutants
Genetic screens for reduced ﬁdelity typically rely on readout
of metabolic reporter genes. However, the levels of the
reporter mRNA and the protein produced during translation
can be below the level required for growth in the absence of
the product of these mRNAs. While suppressor tRNAs are
one mechanism to enhance sensitivity, we hypothesized that
expression of genes under the control of the GAAC pathway
could be increased by elevating the levels of GCN genes. The
effects of GCN2 expression on a series of eEF1A mutations
were assessed via growth on media that reports altered trans-
lational ﬁdelity. All yeast strains used in our studies contain
the his4-713 and met2-1 alleles, where growth on the C-His or
C-Met mediarequires the suppression ofa +1frameshift muta-
tion. They also contain the lys2-20 mutation, where growth
on C-Lys media indicates the suppression of a nonsense muta-
tion. Three eEF1A mutants with point mutations at N153T
(TKY226), D156E N153T (TKY229) and D156N (TKY225)
alter the NKXD GTP-binding consensus element (18).
Although these mutants show modest effects on nonsense
suppression using a sensitive lacZ reporter (19), they do not
allow growth on C-media lacking His, Met or Lys and thus
cannot suppress his4-713, met2-1 or lys2-20 mutations,
respectively. The E122K (TKY252) and E286K (TKY588)
mutations in eEF1A were isolated in a screen for dominant
suppressors of the met2-1 allele (20). While both mutations
allow growth on C-Met when present as the only form of the
protein, neither allows growth on C-Lys (21,22). Thus, eEF1A
mutations that were found in a screen for dominant reduced
translation ﬁdelity or that target GTP hydrolysis did not
show satisfactory results in phenotypic assays scoring for
His prototrophy using the +1 frameshift mutations his4-713.
We reasoned that this could be due to the fact that the reduced
translation ﬁdelity associated with the studied alleles was not
strong enough to yield enough functional HIS4 and MET2
encoded proteins to allow growth on medium lacking His
or Met. Thus, increased mRNA levels of these reporter
genes should allow the production of sufﬁcient amounts of
functional proteins to render cells prototrophic for these amino
acids. Since the transcription of HIS4, and to a lesser extent
MET2, is under the control of GAAC, increased GCN2 and the
resultant increased GCN4 levels should render cells with
a weak reduction in translation ﬁdelity His
+ and potentially
increase Met
+ growth.
To induce increased cellular GCN2 and thus GCN4 levels
a wild-type GCN2 gene or a constitutively active GCN2
c
(E803V) allele on a URA3 CEN-based plasmid (12) was
transformed into a wild-type strain [MC214 (20)] or a strain
expressing one of the mutations in eEF1A. Cells were grown
on C-Ura medium to identify any changes in growth. Neither
the wild-type nor the ﬁve mutant strains showed alterations of
growth on C-Ura medium at 30 C with an empty vector con-
trolorinthepresenceofGCN2orGCN2
c(E803V)(Figure1A,
C-Ura). Analysis of growth in C-Ura-His media that monitors
translational ﬁdelity defects indicated that some mutants
exhibit enhanced growth in the presence of GCN2 or GCN2
c
(E803V). Strains containing eEF1A mutations, E122K
or E286K, showed signiﬁcantly improved growth on C-Ura-
His media when an extra copy of GCN2 or GCN2
c (E803V)
was present (Figure 1A), indicating increased expression of
the his4-713 gene product. This could occur either through
increased suppression of the +1frameshift signalor through an
increase in the level of the his4-713 mRNA. The three other
mutants in the NKXD GTP-binding motif showed no growth
on C-Ura-His with GCN2 or GCN2
c (E803V) present, consis-
tentwith theirlackofaframeshiftsuppressionphenotype(data
not shown). There was no noticeable increase in growth on
C-Ura-Met media, which monitors a +1 frameshift event at
C-Ura
C-Ura
-His
eEF1A      E122K     WT           E286K                    WT
Empty 
Vector
GCN2
GCN2C
A B
C-Ura+
0.5 mg/ml
paromo
C-Ura-His
+ 0.5 mg/ml
paromo
+ 0.5 mg/ml
Figure 1. Excess GCN2 activity allows growth of select eEF1A mutant strains
on C-Ura-His media, indicating increased expression of the his4-713 gene
product. (A) Either an empty vector (pRS316) or a plasmid expressing wild-
typeGCN2ortheconstitutivelyactiveGCN2
cE803Vallelewastransformedin
yeast expressing wild-type eEF1A or the E122K and E286K eEF1A mutants.
Cells were grown on either C-Ura (upper panel) or C-Ura-His (lower panel)
media for 3 days at 30 C. Growth in the absence of His indicates expression of
the product of the his4-713 +1 insertion allele. (B) Growth was monitored for
yeast expressing wild-type eEF1A and the same plasmids as in (A) with the
addition of 0.5 mg/ml paromomycin (paromo).
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transcription factor (23). These observations indicate that the
ﬁdelity reporter system is probably more sensitive due to
increased mRNA levels ratherthan an increased +1frameshift.
There was no growth on C-Lys that monitors nonsense sup-
pression of lys2-20 (data not shown). LYS2 is a target for
GCN4, however, the E122K and E286K eEF1A mutations
were selected speciﬁcally for the suppression of a +1 insertion
and the mutations in the NKXD element have been shown
previously to have extremely low levels of suppression of
nonsense codons. Allele-speciﬁc suppression is common,
and has been observed previously for these eEF1A alleles
as described above (20,21).
To determine if other GCN2
c alleles also cause this effect,
cells expressing wild-type, N153T, E122K or E286K forms of
eEF1A were transformed with plasmids bearing GCN2
c
(M788V) or GCN2
c (M788V-E1591K), which are stronger
constitutive alleles (12). Growth was monitored on C-Ura
and C-Ura-His media and essentially no growth was seen on
C-Ura-His media with the empty vector. GCN2
c (M788V) and
GCN2
c (M788V-E1591K) expressing plasmids resulted in
enhanced growth on C-Ura-His media speciﬁcally in strains
bearing the E122K or E286K forms of eEF1A (data not
shown). The N153T mutants strain showed no growth in
these conditions, similar to the results obtained with the
GCN2
c E803V allele.
We wished to determine if this effect was due to altered
ﬁdelity and was not a consequence of reduced translation
owing to the eEF1A mutants altering the regulation of the
uORFs of GCN4. The effect of GCN2 or GCN2
c (E803V)
was assessed in strains bearing the his4-713 allele and muta-
tions in other translation elongation factors that conferred
similar growth defects and reduced total protein synthesis
to the E122K and E286K eEF1A mutations but do not increase
ribosomal frameshifting or nonsense suppression. Strains with
the F650S mutation in eEF3 (TKY599) (24) or the K120R
S121D I122D mutations in eEF1Ba (TKY243) (14) and the
isogenic wild-type strains failed to show any growth on C-His
or C-Ura-His media in the presence of a plasmid containing
GCN2 or GCN2
c (E803V) (data not shown). Thus, the growth
effect is speciﬁc to a subset of eEF1A mutant strains that
suppress a +1 insertion in the his4-713 allele.
ExcessGCN2orGCN2
c(E803V)increasesparomomycin
sensitivity in strains expressing the wild-type but
not E122K form of eEF1A
The ﬁnding that in strains harboring speciﬁc eEF1A mutations
the overexpression of GCN2, and to a greater extent GCN2
c
(E803V), results in increased growth on C-Ura-His could
indicate increased +1 slippage to produce the HIS4 encoded
protein. Prior work has indicated that increased or decreased
sensitivity to the aminoglycoside antibiotic paromomycin
correlates with reduced translational ﬁdelity (25,26). Paro-
momycin induces altered ﬁdelity by affecting aminoacyl-
tRNA binding to the A-site of the ribosome (27). Accordingly,
if the reduced translation ﬁdelity of eEF1A mutant strains
is not exacerbated by excess GCN2 or GCN2
c (E803V),
these strains should not be expected to show increased sensi-
tivity to paromomycin as compared with strains harboring
native GCN2. To assess this possibility, strains expressing
wild-type eEF1A or the E122K and E286K mutant forms in
the presence of excess GCN2 or GCN2
c (E803V) were assayed
for paromomycin sensitivity as indicated by the inhibition
of growth of a lawn of cells around a disc saturated with
500 mg/ml paromomycin and 1 mM cycloheximide. A
wild-type strain showed a slight increase in paromomycin
sensitivity with excess GCN2. The sensitivity was increased
with GCN2
c (E803V; Table 2). Strains expressing the E122K
and E286K mutants of eEF1A are more sensitive to paro-
momycin than the wild-type strain (21). An E122K mutant
strain showed no response to the effects of GCN2 or GCN2
c
(E803V) on paromomycin sensitivity. GCN2, and to a larger
extent GCN2
c (E803V), suppressed the paromomycin sensi-
tivity of the E286K mutant strain. Thus, while increasing
GCN2 activity slightly increases paromomycin sensitivity in
a wild-type cell, it has little effect in the E122K mutant and
actually decreases paromomycin sensitivity in the E286K
strain. Cycloheximide sensitivity was assessed in comparison
to a drug that also inhibits translation elongation but is not
linked to altered translational ﬁdelity. GCN2 or GCN2
c
(E803V) expression increased cycloheximide sensitivity for
a wild-type or E286K eEF1A strain. Thus, while subtle dif-
ferences are apparent in the interaction between GCN2 levels
and drug sensitivity, these do not correlate with the His
+
phenotype.
Exposure to paromomycin does not increase GCN2 or
GCN2
c induced growth on C-Ura-His
Since some eEF1A mutants reduce ﬁdelity and show enhanced
growth on C-Ura-His in the presence of the his4-713 mutation
with increased GCN2, we assessed if the growth was a result
of a general reduction in ﬁdelity. Cells with the his4-713
mutation were treated in liquid culture with concentrations
of paromomycin that have been shown previously to cause
reduced translational ﬁdelity without affecting cell growth in
S.cerevisiae (28). Otherwise wild-type cells (MC214) contain-
ing the empty vector pRS316, GCN2 or GCN2
c (E803V) were
grown on C-Ura or C-Ura-His media supplemented with paro-
momycin at concentrations of 0.01, 0.1, 0.2 and 0.5 mg/ml.
None of these concentrations inhibited the growth of the yeast
on C-Ura, or allowed growth on C-Ura-His, with or without
GCN2 or GCN2
c (E803V) (Figure 1B and data not shown).
Thus, the general reduction in translational ﬁdelity elicited
Table 2. The addition of GCN2 or GCN2
c E803V results in increased
sensitivity to paromomycin of wild-type but not an eEF1A mutant strain
Strain Paromomycin
(500 mg/ml)
Cycloheximide
(1 mM)
WT (empty) 1.5 mm
a 6.5
WT (GCN2)2 1 0
WT (GCN2
c E803V) 3 11
E122K (empty) 2 10
E122K (GCN2) 1.5 11
E122K (GCN2
c E803V) 1.75 11
E286K (empty) 9 11
E286K (GCN2) 7.5 12
E286K (GCN2
c E803V) 5.5 15
aRadiusofthehaloofinhibitionofgrowthsurroundingafilterdiscwith10mlof
the indicated concentration of drug.
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phenotype of his4-713 cells even in the presence of elevated
GCN2 function. This is consistent with the interpretation that
the growtheffectsseen onC-Hiswiththe eEF1Amutationsare
not due to reduced ﬁdelity affecting expression independent of
the frameshift speciﬁc effects of these mutants.
Conditions that reduce fidelity in yeast do not increase
GCN4 expression
Since GCN4 expression is under translational control via four
uORFs (6), we sought to understand the interplay between
translational ﬁdelity and the GCN4 regulation system using
well-characterized mechanisms to alter translational ﬁdelity.
In order to speciﬁcally assay if altered ﬁdelity affects GCN4
expression, cells were treated with paromomycin at increasing
concentrations from 0.2 to 1.0 mg/ml and the expression
of GCN4 was determined using a GCN4-lacZ reporter con-
struct (8). Isoleucine/valine/leucine starvation was induced by
growth in C-Ura-Val-Ile to exponential phase followed by the
addition of SM for 6 h. Mutants with defects in inducing
translation of GCN4 were unable to increase the expression
of GCN4-regulated genes and, therefore, were unable to over-
come isoleucine/valine/leucine starvation (15). Paromomycin
treatment produced essentially no effect on GCN4-lacZ
expression under non-starvation conditions (Table 3). Under
starvation conditions without drug, GCN4-lacZ expression
was elevated as expected, however, the addition of paro-
momycin reduced GCN4-lacZ expression. The paromomycin
concentration inversely correlated with the amount of GCN4-
lacZ derepression (Figure 2A), with the highest paromomycin
concentration inhibiting GCN4-lacZ derepression. This effect
was not due to paromomycin altering cell growth (Figure 2B).
The doubling times showed no signiﬁcant change at the two
lowest levels of treatment 0.2 mM (163.3 ± 14.4 min) and
0.5 mM (169.3 ± 1.2 min) paromomycin, compared with
the absence of drug (147.3 ± 5.7 min). A slight increase in
doubling time was observed at 1.0 mM paromomycin
(196 ± 1.7 min). Thus, altered translation ﬁdelity does not
lead to increased GCN4 expression.
Table 3. Translation elongation inhibitors, paromomycin and cycloheximide, do not increase lacZ-GCN4 expression and differentially affect derepression
Paromomycin (mg/ml) GCN4-LacZ   SM GCN4-LacZ + SM Cycloheximide (ng/ml) GCN4-LacZ   SM GCN4-LacZ + SM
0 115.5 ± 6.4
a 216.5 ± 30.5 0 79.5 ± 13.4 125.6 ± 8.5
0.2 127.6 ± 7.2 165.5 ± 6.8 0.1 84.0 ± 1.3 150.1 ± 9.2
0.5 109.9 ± 9.1 150.8 ± 16.2 1 87.1 ± 12.0 141.2 ± 8.3
1.0 96.6 ± 6.7 101.0 ± 3.2 10 25.9 ± 2.1 82.0 ± 2.5
ab-Galactosidase activity (lacZ units).
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Ile + 2mg/mlSMfor6h)conditionsatconcentrationsofparomomycinrangingfrom0to1.0mg/ml.(B)Cellsweregrowninmid-logphaseinC-Uramediumwith0
(diamonds),0.2(squares),0.5(triangles)or1.0(circles)mg/mlparomomycin(paromo)in96-wellplateswithconstantshakingat30 CandmonitoredfortheOD600.
ExpressionofGCN4-lacZ(C)andgrowthrates(D)weredeterminedasin(A)and(B),respectively,with0(diamonds),0.1(squares),1.0(triangles)or10.0(circles)
10 mg/ml cycloheximide (CHX).
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altering ﬁdelity, cells were treated with 0–1 ng/ml cyclohex-
imide, concentrations were chosen based on prior work (29).
Treatment with cycloheximide, a drug that inhibits the pep-
tidyl transferase activity of the ribosome, at 0.1 or 1 ng/ml
resulted in no effect on GCN4 expression under non-starvation
conditions (Table 3) or on the level of derepression
(Figure 2C). These same concentrations showed no effect
on the growthof the cells (Figure2D).When cells were treated
with high concentrations of drug (10 ng/ml), GCN4 expression
was inhibited more under non-starvation than under starvation
conditions (Table 3), giving an apparent increase in derepres-
sion (Figure 2C).
In order to alter translational ﬁdelity without inhibiting
translation elongation, the effect of the element [PSI+],
a prion form of the translation termination factor eRF3, was
assessed. The presence of [PSI+] results in increased nonsense
suppression [reviewed in (30)]. Utilizing isogenic [psi ] and
[PSI+] strains (5), no effect of [PSI+] was seen on GCN4
expression under non-starvation conditions (Table 4). The
derepression of GCN4 under starvation conditions was
reduced in the presence of [PSI+] (Figure 3A). This was not
due to different growth characteristics of [psi ] and [PSI+]
strains (Figure 3B). Thus, in strains with reduced ﬁdelity due
to either the presence of [PSI+] or paromomycin treatment, the
derepression of GCN4 is reduced. This indicates that GCN4
expression and derepression are sensitive to conditions that
alter translational ﬁdelity.
eEF1A mutants show allele-specific effects on
GCN4 expression
To understand the starting levels of GCN4 expression that are
the baseline for the GCN2 effect, we directly assessed the
effect of mutant forms of eEF1A on GCN4 expression using
the lacZ-based reporter assays. The assay was performed in
strains expressing mutant forms of eEF1A that either fail to
show increased growth on C-Ura-His media in the presence of
excess GCN2 activity (N153T, D156E N153T and D156N) or
the two mutants with enhanced growth under these conditions
(E122K and E286K). Previous work had demonstrated that
strains bearing N153T, D156E N153T and D156N show
essentially wild-type rates of total protein synthesis (19),
while strains with either E122K or E286K show a 50% reduc-
tion in total translation (24). Expression of the GCN4 reporter
under non-starvation conditions was essentially the same for
wild-type and D156N mutants strains and was slightly reduced
for N153T and N153T D156E mutant strains (Table 5).
Expression was dramatically reduced for E122K and E286K
mutants to 30% or less of the wild-type level. When compared
with expression under starvation conditions, the fold derepres-
sion was slightly increased for strains expressing the N153T,
D156E N153T and D156N mutations but dramatically
increased for expressing the E122K (7.1-fold) and E286K
(12.9-fold) mutations to levels 3.7–6.8 times the derepression
observed in strains expressing the wild-type eEF1A (Figure 4).
Table 4. The presence of [PSI+], which reduces translational fidelity, reduces
GCN4-LacZ derepression
Strain GCN4-LacZ   SM GCN4-LacZ + SM
WT [psi ] 29.2 ± 2.9
a 202.0 ± 13.3
WT [PSI+] 33.7 ± 5.6 123.2 ± 12.5
ab-Galactosidase activity (lacZ units).
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Figure 3. Reduced derepression of GCN4-LacZ is seen in the presence of
increased nonsense suppression by [PSI+]. (A) Expression of GCN4 was
determined using a lacZ-based reporter construct (p180) and the fold derepres-
sion determined as described in Figure 2 in otherwise isogenic strains without
[psi ] or with [PSI+]. (B)[ psi ] (open circle) or [PSI+] (open squares) cells
were grown in mid-log phase in Complete medium in 96-well plates with
constant shaking at 30 C and growth monitored by the OD600.
Table5.ExpressionofGCN4-LacZisreducedundernon-starvationconditions
in E122K and E286K eEF1A mutant strains
eEF1A GCN4-LacZ activity   SM GCN4-LacZ activity + SM
WT 63.5 ± 6.0
a 124.1 ± 6.5
D156N 70.3 ± 2.2 211.7 ± 29.6
N153T 39.9 ± 2.8 106.6 ± 11.7
N153T D156E 41.5 ± 2.5 165.9 ± 8.1
E122K 18 ± 3.4 128.9 ± 6.3
E286K 14 ± 2.1 128.9 ± 8.8
ab-Galactosidase activity (lacZ units).
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Figure 4. Starvation induces enhanced GCN4-LacZ derepression in strains
containing E122K or E286K eEF1A mutants. Expression of GCN4 was deter-
mined using a lacZ-based reporter construct (p180) and the fold derepression
determined as in Figure 2 for strains expressing wild-type (MC214), N153T
(TKY226), D156E N153T (TKY229), D156N (TKY225), E122K (TKY252)
and E286K (TKY588) forms of eEF1A (19–22).
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in all cases. Comparison of the absolute expression levels
between strains with wild-type, N153T, E122K and E286K
mutants, however, were all within experimental error
(Table 5). Thus, while the fold derepression was dramatically
increased, the total level of GCN4 expression under starvation
conditions was the same. Thus, it does not appear that the
increased growth of his4-713 mutant in C-Ura-His was due
to an excessive increase in GCN4 expression caused by select
eEF1A mutations under starvation or normal conditions but
instead the growth effects are caused by the interplay of excess
GCN2 activity and the presence of select alleles of eEF1A that
suppress a +1 frameshift mutation.
Increased GCN4 is sufficient for increased growth of
strains bearing a his4-713 mutation and specific
eEF1A mutations that suppress the +1 insertion
Since the results support the model that GCN4 expression is
increased by GCN2 levels and thus his4-713 mRNA levels, we
bypassed the GCN2-mediated induction by utilizing a series of
GCN4 expressing plasmids with modiﬁcations in the uORFs
that regulate GCN4 expression (13). The wild-type GCN4
expression plasmid has all four uORFs, and its expression
is subject to GCN2 regulation. The GCN4 construct containing
only uORF1 has released some of the repression of GCN4
expression, and the GCN4 lacking all uORFs is expressed
constitutively, leading to constitutive transcription of GCN4-
regulated genes including his4-713. As shown in Figure 5,
a strain expressing the N153T mutant or wild-type eEF1A
shows no growth on C-Ura-His with any GCN4 plasmid. Both
E122K and E286K mutant strains, however, show growth
with the uORF1 and no ORF GCN4 constructs. This shows
that the eEF1A speciﬁcity is the same as seen with elevated
GCN2 expression or activity. The transformation efﬁciency
of the GCN4 overexpression constructs and stable growth of
the transformed strains is signiﬁcantly lower than the GCN2
plasmids, indicating these may be less optimal for use in
screening applications.
The E122K eEF1A mutant shows reduced expression
of the HIS4 mRNA
The levels of growth on C-Ura medium and the difference in
levels of GCN4 activation in wild-type versus the E122K
eEF1A mutant support a model where the E122K mutant
has reduced levels of GCN4 expression relative to wild-
type and that consequently this strain is more sensitive to
increased GCN4 activity. To conﬁrm these results in increased
HIS4 expression, a northern blot was performed on wild-type
and E122K eEF1A strains expressing a vector alone, a plasmid
expressing a constitutively active GCN2
c E803V, GCN4 with
only uORF1 or GCN4 with no uORFs. As shown in a repre-
sentative blot in Figure 6A, HIS4 mRNA levels are higher in
the wild-type strain than in the E122K mutant with the empty
vectorandaregrowninC-Uramedium.TheadditionofGCN2
c
E803V or GCN4 overactive or overexpressing plasmids
increased the expression of HIS4 mRNA in the E122K mutant
strain. Thus, the eEF1A mutant is more strongly repressed for
GNC4 activity, and thus responds to elevated GCN2 and
GCN4 expression and results in enhanced GCN4 induction
under starvation conditions as shown in Figure 4.
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C-Ura
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Figure 5. OverexpressionofGCN4promoteseEF1Aallele-specificgrowthon
C-Ura-His.Eitheranemptyvector(pRS316)oraplasmidexpressingwild-type
GCN4,GCN4withonlyuORF1andGCN4withnouORFsweretransformedin
yeast expressing wild-type eEF1A or the E122K, N153T and E286K eEF1A
mutants. Cells weregrown on either C-Ura(upperpanels) or C-Ura-His (lower
panels) for 3 days at 30 C.
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Figure 6. Overexpression of GCN4 promotes higher HIS4 expression in an
eEF1AE122Kmutantstrain.(A)Eitheranemptyvector(pRS316)oraplasmid
expressing a constitutively active GCN2
c E803V, GCN4 with only uORF1 or
GCN4 with no uORFs. Cells were grown in C-Ura, RNA extracted and HIS4
and ACT1 mRNAs detected. (B) HIS4 levels were normalized to ACT1 levels
persampleandwerethenexpressedastheratioofthatsampletothesamestrain
expressing an empty vector. The average is shown.
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In our studies we report an improved procedure that allows
enhanced in vivo scoring of translation ﬁdelity phenotypes.
The assay takes advantage of the GAAC system and the fact
that many reporter genes used to score for translation ﬁdelity
are upregulated by GAAC. Increased GCN2 activity leads to
increasedexpression ofhis4-713duetoincreasedGCN4trans-
lation. Increased his4-713 mRNA levels allow factors that
impair protein synthesis and thus translate sufﬁcient amounts
of functional his4-713 encoded protein to allow cells to grow
in the absence of histidine. A plasmid construct harboring the
GCN4 gene with all four uORFs is subject to translational
repression and fails to induce growth of the eEF1A E122K
or E286K mutations on C-Ura-His media. Removing uORF2,
uORF3 and uORF4 leads to increased GCN4 protein levels
and growth on C-Ura-His, and further removal of all uORFs
resulted in the highest growth. Thus, increasing GCN4 levels
gives the same result as increasing GCN2 levels or activity.
This supports the model that constitutively increased his4-713
mRNA levels results in increased sensitivity of the translation
ﬁdelity assay (Figures 1 and 5). Since GCN4 should be dere-
pressed on C-His medium, this system must hyper-induce the
level of GCN4 to enhance the assay.
The ability to enhance sensitivity of assays of frameshift or
nonsense suppression more generally, without requiring a spe-
ciﬁcnonsense-containingallele/suppressortRNApairssuchas
is commonly used for the analysis of [PSI+], has implications
in enhanced isolation and characterization of mutations that
alter translational ﬁdelity. The use of GCN2 or GCN4 expres-
sion has advantages over current approaches. It is not speciﬁc
to a single stop codon or +1o r 1 frameshift signal-like
suppressor tRNA mutations. Thus, in a single strain with mul-
tiple alleles it may be possible to simultaneously enhance the
sensitivity of suppression of multiple target genes responsive
to GCN4 expression. This system is also preferable to the
overexpression of a speciﬁc reporter mRNA, such as that
encoded by his4-713, since expression with a constitutive pro-
moter may lead to a very high level of expression that will give
a positive growth phenotype. Further, it is possible to vary the
sensitivity by using GCN2
c alleles of varying severity. This
system is easy to move between strain and with the enhanced
sensitivity may allow for the comparison of mutants with
intermediate effects on ﬁdelity.
Since the GCN2/GCN4 system is regulated at the level of
translation, the effects of reduced translation or ﬁdelity on
GCN4 expression were determined. Paromomycin was
utilized to induce A-site errors related to aminoacyl-tRNA
binding and presentation, and the [PSI+] form of eRF3 was
utilized to speciﬁcally affect nonsense suppression. Both con-
ditions reduced GCN4 expression under starvation conditions.
This could be due to increased readthrough of the uORF stop
codons, elongating the uORF sequences to inhibit initiation at
the GCN4 AUG.
We directly studied the GCN4 expression in strains harbor-
ing various eEF1A alleles that reduce ﬁdelity by using the
GCN4-lacZ reporter gene. The eEF1A E122K and E286K
mutations reduced the expression of GCN4 under non-
starvation conditions while not affecting GCN4 expression
levels under isoleucine/valine/leucine starvation, thereby
accounting for the signiﬁcantly increased level of GCN4
derepression. This might be due to the slowed elongation,
as this effect correlates with those eEF1A mutants that
show reduced total translation and elongation in vivo (24).
eEF1A mutations do not, however, affect the expression of
GCN4 under amino acid starvation conditions. This effect is
further seen by northern blot analysis of the mRNA levels of
the GCN4 target gene HIS4. The E122K mutant shows an
increase in HIS4 expression in the presence of overactive
or overexpressed GCN2 or GCN4, consistent with the
enhanced growth on C-Ura-His medium. The E122K mutant
also shows much lower expression of HIS4 with the empty
vector compared with the isogenic wild-type eEF1A strain.
This correlates with the greater derepression seen for GCN4
under SM starvation and supports the observation that the
eEF1A mutant strains show reduced GCN4 expression.
The eEF1A E122K and E286K mutant strains or treatment
of yeast with high levels of cycloheximide partially suppress
the level of GCN4 expression. Since these are independent
mechanisms that reduce translation, it is possible that the
reduced elongation rates at uORF2, uORF3 or uORF4 could
slow down scanning in the GCN4 leader. The model of GCN4
regulation proposed by Grant et al. (13) indicates that slowing
of elongation at uORF4 could lead to ribosomes accumulating
upstream of the uORF4. Thus, reduced elongation could favor
re-inititation at uORF2, uORF3 or uORF4 when TC levels are
high and the ribosomes have to longer bind TC. However,
under starvation conditions when TC levels are lower, the
ribosomes queued in the GNC4 leader would diminish, thus
restoring the regulation to normal levels as we observe. Thus,
the regulation of uORFs is subject to altered efﬁciency with
altered translation elongation rates or ﬁdelity.
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